Despite a mixed fourth-quarter revenue performance, British pharmaceutical giant GSK remains optimistic about its long-term growth prospects, particularly with its ambitious revenue target for 2031.

If you need to fly with medication, you may have a moment of panic while packing, wondering whether you can take pills or liquid or injectable medicines on a plane or travel with prescription ...

In October, when GSK agreed to a $2.2 billion settlement to resolve approximately 80,000 lawsuits brought by users of Zantac, it appeared that the drugmaker’s legal issues with the heartburn ...

In 2019, independent laboratory Valisure found NDMA, a cancer-causing poison, in "every batch of every [Zantac] medication" that it tested. Valisure reported these results to the U.S. Food and Drug ...

In 2019, independent laboratory Valisure found NDMA, a cancer-causing poison, in "every batch of every [Zantac] medication" that it tested. Valisure reported these results to the U.S. Food and ...

Global pharmaceutical company GSK Plc allegedly deceived investors when it concealed for decades an internal study implicating a link between the heartburn drug Zantac and cancer, a proposed class ...